Senior insider sale
Chief Financial Officer at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$31.2K
10.23K shares
What this filing means
NOUGUES MAXIMO F plans to sell 10.23K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $31.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/2/2025ACC: 0001610717-25-000004
Officer· Chief Financial Officer
Since Nov 2018
10.23K
Shares to sell
$31.2K
Approx. market value
101.91K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Unit Grant
Compensation for Services Rendered
2/12/2024
43.31KRestricted Stock Unit Grant
Compensation for Services Rendered
2/10/2023
58.60KTotal acquired101.91K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/12/2024 | Restricted Stock Unit Grant Compensation for Services Rendered | 43.31K | — |
2/10/2023 | Restricted Stock Unit Grant Compensation for Services Rendered | 58.60K | — |
| Total | 101.91K | ||
Planned & Completed Dispositions1
NASDAQGSPlanned
Units to sell
10.23K
Market value
$31.2K
1/2/2025
Total
Units
10.23K
Value
$31.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/2/2025 | 10.23K | $31.2K | NASDAQGS | Planned |
| Total | 10.23K | $31.2K | ||